The use of NHS databases to identify and manage pharmacotherapy in people with dementia and/or late-life mental disorders
Expert Review of Clinical Pharmacology · 2025
DOI: 10.1080/17512433.2025.2576102 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Expert Review of Clinical Pharmacology, 2025. Verfasst von Harsharon Kaur Sondh und 3 weiteren Autor:innen. Beteiligte Einrichtung: King's College London, Institute of Psychiatry, Psychology and Neuroscience (IoPPN) London, UK. Hauptthemen laut MEDLINE: Dementia, Mental Disorders, Databases, Factual. Die Arbeit nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIHR Maudsley Biomedical Research Centre, NIHR HealthTech Research Centre in Brain Health, UKRI – Medical Research Council.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION: Older people with dementia and mental health disorders frequently have co-occurring acute and chronic conditions resulting in polypharmacy. However, these populations are under-represented in clinical trials, and drug efficacy and tolerability are poorly understood. Electronic health records data represent valuable resources to investigate medication safety. AREAS COVERED: This report outlines the complexity of pharmacotherapy in late life and the key factors that need to be taken into consideration. In relation to the impoverished evidence base to support prescribing, it considers the important potential role of electronic health records data resources in addressing this, particularly within the UK National Health Service (NHS). The different types of current NHS databases in specialist and primary care are discussed alongside research outputs using these resources related to pharmacotherapy in people with dementia and/or late life mental disorders. EXPERT OPINION: NHS databases have particular value because of comprehensive catchment-based care provided by mental health and dementia diagnostic services and detailed long-term prescribing data captured in primary care. However, care for these disorders is usually delivered across multiple sectors with differing strengths and limitations in information availability and more work is needed in improving linked data infrastructures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- King's College London, Institute of Psychiatry, Psychology and Neuroscience (IoPPN) London, UK.
- Department of Old Age Psychiatry, South London and Maudsley NHS Foundation Trust, London, UK.
Förderung
- NIHR Maudsley Biomedical Research Centre
- NIHR HealthTech Research Centre in Brain Health
- UKRI – Medical Research Council
- UK Prevention Research Partnership
Zitieren
APA
Sondh, H. K., Mueller, C., Bishara, D., & Stewart, R. (2025). The use of NHS databases to identify and manage pharmacotherapy in people with dementia and/or late-life mental disorders. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2025.2576102
Vancouver
Sondh HK, Mueller C, Bishara D, Stewart R. The use of NHS databases to identify and manage pharmacotherapy in people with dementia and/or late-life mental disorders. Expert Review of Clinical Pharmacology. 2025. doi:10.1080/17512433.2025.2576102
BibTeX
@article{Sondh2025,
author = {Sondh, Harsharon Kaur and Mueller, Christoph and Bishara, Delia and Stewart, Robert},
title = {The use of NHS databases to identify and manage pharmacotherapy in people with dementia and/or late-life mental disorders},
journal = {Expert Review of Clinical Pharmacology},
year = {2025},
doi = {10.1080/17512433.2025.2576102}
}
EUVIMED